Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
a Clinical Study to Assess Gingivitis
NCT06659471Completed
- Sponsor
- Procter & Gamble
- Start
- Mar 2022
- Primary completion
- Jun 2022
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Randomised, double-blind trial of stannous fluoride in gingivitis (4 arms), sponsored by Procter & Gamble. Primary endpoint: Number of Bleeding Sites at 3 months. Started Mar 2022; status: completed.
02
Drugs
stannous fluoride
03
Conditions
gingivitis
Beyond the preview
Go deeper on NCT06659471.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06659471.